RELMADA THERAPEUTICS INC (RLMD)

US75955J4022 - Common Stock

3.34  -0.15 (-4.3%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2024-3-31)		 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-94.30M-98.79M-157.04M-125.75M-59.46M
Depreciation Amortization
N/AN/A0.000.000.00
Change In Working Capital
4.59M3.08M10.59M-7.86M10.85M
Interest Paid
N/AN/AN/A0.000.00
Taxes Paid
N/AN/AN/AN/A0.00
Other non cash items
41.51M44.05M42.65M41.74M20.79M
OPERATING CASH FLOW
-48.19M-51.66M-103.80M-91.87M-27.81M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/AN/AN/AN/AN/A
Other Investing Activity
20.51M50.45M19.73M-54.12M-34.45M
INVESTING CASH FLOW
20.51M50.45M19.73M-54.12M-34.45M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/AN/A0.00-110.00K
Stock Issued/Repurchased
246.75K0.0044.65M187.94M28.58M
Other Financing Activity
N/A-98.46K370.00KN/AN/A
FINANCING CASH FLOW
123.29K-98.46K45.02M187.94M28.47M
 
CHANGE IN CASH
-27.55M-1.30M-39.05M41.95M-33.79M
 
FREE CASH FLOW
Operating Cash Flow
-48.19M-51.66M-103.80M-91.87M-27.81M
Capital Expenditure
N/AN/AN/AN/AN/A
FREE CASH FLOW
-48.19M-51.66M-103.80M-91.87M-27.81M

All data in USD

Charts